DUTASTERIDE
Substance profile for UNII O0J6XJN02I, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 6918296Substance Identity#
- UNII
- O0J6XJN02I
- Preferred term
- DUTASTERIDE
- Registry number
- 164656-23-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C27H30F6N2O2
Structure render from PubChem CID 6918296Chemical And Database Identifiers#
- InChIKey
- JWJOTENAMICLJG-QWBYCMEYSA-N
- SMILES
- C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
- RxCUI
- 228790
- PubChem
- 6918296
- NCIt
- C47503
- INN ID
- 7586
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 2010 | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN. JALYN (dutasteride and tamsulosin hydrochloride) Capsules Initial U.S. Approval: 2010 | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin Capsules Initial U.S. Approval: 2001 | 2 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin Capsules Initial U.S. Approval: 2001 | 2 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL & SURGCIAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3766 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [LAKE ERIE MEDICAL & SURGCIAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3766 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 21 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | AVODART (DUTASTERIDE) CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 21 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE) CAPSULE [GLAXOSMITHKLINE LLC] | 14 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | JALYN (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE) CAPSULE [GLAXOSMITHKLINE LLC] | 14 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE [ACTAVIS PHARMA, INC.] | 10 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE [ACTAVIS PHARMA, INC.] | 10 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES) CAPSULE [PAR PHARMACEUTICAL] | 7 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES) CAPSULE [PAR PHARMACEUTICAL] | 7 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [APOTEX CORP.] | 2 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [APOTEX CORP.] | 2 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | BAKUMOKON 5% MINOXIDIL (MINOXIDIL, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | BAKUMOKON 5% MINOXIDIL (MINOXIDIL, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | BAKUMOKON 7% MINOXIDIL SULFATE (MINOXIDIL SULFATE, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | BAKUMOKON 7% MINOXIDIL SULFATE (MINOXIDIL SULFATE, DUTASTERIDE, OXYTOCIN) LIQUID [DS LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE (DUTASTERIDE) CAPSULE [AVKARE, INC.] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE (DUTASTERIDE) CAPSULE [AVKARE, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE [BRECKENRIDGE PHARMACEUTICAL, INC.] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE [ROXANE LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE [ROXANE LABORATORIES, INC.] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [GLAXOSMITHKLINE LLC] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [RISING PHARMACEUTICALS, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [RISING PHARMACEUTICALS, INC.] | 1 | |
| DUTASTERIDE | ACTIVE INGREDIENT | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 1 | |
| DUTASTERIDE | ACTIVE MOIETY | O0J6XJN02I | DUTASTERIDE CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 1 | |